Azimed® Tablets

Azimed® Tablets
Product Description


Each film-coated tablet contains 500 mg azithromycin (in form of azithromycin dehydrate, excipients.

Box with 3 film coated tablets of 500 mg in blister package.

Replek Farm Ltd

  • MK
  • 2022
    On CPHI since
  • 250 - 499
    Employees
Specifications
  • Selling Points
    International Approvals/Standards; Place of Origin; Price; Quality Service
  • Model
    Film - Coated Tablets 3 × 500 mg
  • Measured In
    mg

Replek Farm Ltd

  • MK
  • 2022
    On CPHI since
  • 250 - 499
    Employees

More Products from Replek Farm Ltd (4)

  • Ibuprofen Aktiv® Tablets

    Product Ibuprofen Aktiv® Tablets


    1 film-coated tablet contains 200 mg or 400 mg ibuprofen.

    Box of 30 film-coated tablets of 200 mg in a blister pack.

    Box of 10 film-coated tablets of 400 mg in a blister pack.

    Box of 30 film-coated tablets of 400 mg in a blister pack.

  • Oralsept® Spray

    Product Oralsept® Spray

    1 ml solution contains 1.5 mg benzidamine hydrochloride.

    Box with a plastic container of 30 ml spray with a dosing pump.
  • Revagra® Tablets

    Product Revagra® Tablets

    Each film-coated tablet contains 50mg / 100mg sildenafil (in form of sildenafil citrate).

    Box with 4 film-coated tablets of 50 mg in blisters.

    Box with  4 film-coated tablets of 100 mg in blisters.
  • Neuro-Vit®

    Product Neuro-Vit®

    COMPOSITION

    Each film-coated tablet contains:

    100 mg thiamin hydrochloride (B1)
    200 mg Pyridoxine hydrochloride (B6)
    0.2 mg Cyanocobalamin (B12)

Replek Farm Ltd resources (1)

  • Video Replek - 20 Years Anniversary

    Our concept and our main goal was construction and establishment of a modern factory for production of pharmaceuticals, which was completed in 2001.
    Designed, built and equipped in accordance with the latest requirements for good manufacturing practice and the most stringent requirements for environmental protection, today the factory is a modern, operational, high-standardized production capacity.
    The facility can produce more than 150 drugs registered in our country and numerous foreign markets, in accordance with the strictest requirements for quality and safety of medicines.
    Our future goal is continuous implementation of new technologies in operation, building new capacities, expanding the product range, increasing the number of exporting partners and achieving greater cost-effectiveness.